4/A//SEC Filing
Wanstall Rick 4/A
Accession 0000899243-22-012856
CIK 0001420565other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 8:32 PM ET
Size
5.7 KB
Accession
0000899243-22-012856
Insider Transaction Report
Form 4/AAmended
Wanstall Rick
VP, Finance and Operations
Transactions
- Award
Stock Option (right to buy)
2022-03-30+393,000→ 393,000 totalExercise: $0.48Exp: 2032-03-29→ Common Stock (393,000 underlying)
Footnotes (2)
- [F1]This amendment is being filed to correct the date of grant and the exercise price for the stock option reported on a Form 4 filed by the reporting person on March 24, 2022. This option became effective on March 30, 2022.
- [F2]The shares underlying the option are scheduled to vest in equal monthly installments through March 30, 2026.
Documents
Issuer
AILERON THERAPEUTICS INC
CIK 0001420565
Entity typeother
Related Parties
1- filerCIK 0001771222
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 8:32 PM ET
- Size
- 5.7 KB